130 related articles for article (PubMed ID: 30927333)
1. Association between LINC00657 and miR-106a serum expression levels and susceptibility to colorectal cancer, adenomatous polyposis, and ulcerative colitis in Egyptian population.
Shaker OG; Ali MA; Ahmed TI; Zaki OM; Ali DY; Hassan EA; Hemeda NF; AbdelHafez MN
IUBMB Life; 2019 Sep; 71(9):1322-1335. PubMed ID: 30927333
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression.
Hu B; Cai H; Zheng R; Yang S; Zhou Z; Tu J
Int J Biochem Cell Biol; 2017 Nov; 92():34-42. PubMed ID: 28919047
[TBL] [Abstract][Full Text] [Related]
3. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
[TBL] [Abstract][Full Text] [Related]
4. LINC00657 promotes colorectal cancer stem-like cell invasion by functioning as a miR-203a sponge.
Zhao L; Liu C; Yan S; Hu G; Xiang K; Xiang H; Yu H
Biochem Biophys Res Commun; 2020 Aug; 529(2):500-506. PubMed ID: 32703458
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
[TBL] [Abstract][Full Text] [Related]
6. "Salivary LINC00657 and miRNA-106a as diagnostic biomarkers for oral squamous cell carcinoma, an observational diagnostic study".
Tarrad NAF; Hassan S; Shaker OG; AbdelKawy M
BMC Oral Health; 2023 Dec; 23(1):994. PubMed ID: 38087258
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs expression profiling in Egyptian colorectal cancer patients.
Bader El Din NG; Ibrahim MK; El-Shenawy R; Salum GM; Farouk S; Zayed N; Khairy A; El Awady M
IUBMB Life; 2020 Feb; 72(2):275-284. PubMed ID: 31512372
[TBL] [Abstract][Full Text] [Related]
8. Differential Expression of miR-21, miR-23a, and miR-27a, and Their Diagnostic Significance in Egyptian Colorectal Cancer Patients.
Farouk S; Khairy A; Salem AM; Soliman AF; Bader El Din NG
Genet Test Mol Biomarkers; 2020 Dec; 24(12):825-834. PubMed ID: 33290159
[No Abstract] [Full Text] [Related]
9. Association of MALAT1 and PVT1 Variants, Expression Profiles and Target miRNA-101 and miRNA-186 with Colorectal Cancer: Correlation with Epithelial-Mesenchymal Transition.
Radwan AF; Shaker OG; El-Boghdady NA; Senousy MA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200314
[TBL] [Abstract][Full Text] [Related]
10. Differential Expression of Serum TUG1, LINC00657, miR-9, and miR-106a in Diabetic Patients With and Without Ischemic Stroke.
Abdelaleem OO; Shaker OG; Mohamed MM; Ahmed TI; Elkhateeb AF; Abdelghaffar NK; Ahmed NA; Khalefa AA; Hemeda NF; Mahmoud RH
Front Mol Biosci; 2021; 8():758742. PubMed ID: 35237654
[No Abstract] [Full Text] [Related]
11. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
[TBL] [Abstract][Full Text] [Related]
12. Associations between markers of colorectal cancer stem cells, mutation, microRNA and the clinical features of ulcerative colitis.
Yang L; Levi E; Du JH; Zhou HH; Miller R; Majumdar AP
Colorectal Dis; 2016 Jun; 18(6):O185-93. PubMed ID: 27153478
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
14. Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma.
Li J; Liu Y; Wang C; Deng T; Liang H; Wang Y; Huang D; Fan Q; Wang X; Ning T; Liu R; Zhang CY; Zen K; Chen X; Ba Y
Sci Rep; 2015 Aug; 5():12921. PubMed ID: 26250939
[TBL] [Abstract][Full Text] [Related]
15. The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients.
Lewis A; Felice C; Kumagai T; Lai C; Singh K; Jeffery RR; Feakins R; Giannoulatou E; Armuzzi A; Jawad N; Lindsay JO; Silver A
PLoS One; 2017; 12(3):e0173664. PubMed ID: 28288169
[TBL] [Abstract][Full Text] [Related]
16. miR-106a Reduces 5-Fluorouracil (5-FU) Sensitivity of Colorectal Cancer by Targeting Dual-Specificity Phosphatases 2 (DUSP2).
Qin Y; Chen X; Liu Z; Tian X; Huo Z
Med Sci Monit; 2018 Jul; 24():4944-4951. PubMed ID: 30011263
[TBL] [Abstract][Full Text] [Related]
17. Low-level serum miR-24-2 is associated with the progression of colorectal cancer.
He HW; Wang NN; Yi XM; Tang CP; Wang D
Cancer Biomark; 2018 Feb; 21(2):261-267. PubMed ID: 29171985
[TBL] [Abstract][Full Text] [Related]
18. Serum
Wang N; Zeng L; Li Z; Zhen Y; Chen H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2650-2653. PubMed ID: 31240955
[TBL] [Abstract][Full Text] [Related]
19. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
20. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]